Skip to main content

Table 1 Clinical features of UCS and CCS n (%)

From: Clinical and imaging features of carcinosarcoma of the uterus and cervix

Features UCS (n = 37) CCS (n = 4) p value
Age, years 59.92 ± 7.40 69.25 ± 6.40 0.020
Childbearing history 3 (2, 3) 3.50 (2.25, 5.50) 0.190
Chief complaint
Vaginal bleeding 29 (78.37) 4 (100) 0.569
Other 8 (21.62) 0  
Duration
≤ 2 month 24 (64.86) 1 (15) 0.311
> 2 month 13 (35.14) 3 (75)  
Postmenopausal
Yes 36 (97.29) 4 (100) 1.000
No 1 (2.7) 0  
AFP
Elevated/normal 3/34 0/4 1.000
CEA
Elevated/normal 0/37 0/4
CA199
Elevated/normal 3/34 0/4 1.000
CA125
Elevated/normal 13/24 0/4 0.385
CA153
Elevated/normal 1/36 0/4 1.000
CA724
Elevated/normal 1/36 0/4 1.000
Invasion depth
≤ 1/2 myometrium 19 (51.35)
> 1/2 myometrium 18 (48.64)  
Stage
IA/ IB 17/9 4 0.496
II 1 0  
IIIA/B/C1/C2 2/1/1/2 0  
IVB 4 0  
  1. Bold value means p < 0.05
  2. UCS uterine carcinosarcoma, CCS cervical carcinosarcoma, AFP alpha-fetoprotein, CEA carcinoembryonic antigen, CA199 carbohydrate antigen 199, CA125 carbohydrate antigen 125, CA153 carbohydrate antigen 153, CA724 carbohydrate antigen 724